Literature DB >> 1395742

Interleukin 6 activity in pleural effusion. Its diagnostic value and thrombopoietic activity.

A Yokoyama1, M Maruyama, M Ito, N Kohno, K Hiwada, S Yano.   

Abstract

We measured interleukin 6 (IL-6) concentrations in the pleural fluid of various patients to determine its role in pathophysiology and diagnosis by using specific functional bioassay. IL-6 levels were significantly higher in exudate than in transudate (79.3 +/- 176.2 U/ml [n = 55] vs 1.7 +/- 1.8 U/ml [n = 12]; p < 0.01). Tuberculous effusion contained a significantly higher amount of IL-6 than malignant effusion (181.3 +/- 176.2 U/ml [n = 13] vs 29.4 +/- 71.5 U/ml [n = 29]; p < 0.005). Pleural IL-6 levels were invariably higher than serum IL-6 levels, and both were significantly correlated (n = 21, r = 0.632; p < 0.02). Pleural IL-6 levels were significantly correlated with lactate dehydrogenase (LDH) in pleural fluid (r = 0.392; p < 0.01), ratio of pleural/serum LDH (r = 0.571; p < 0.01), pleural adenosine deaminase activity (r = 0.599; p < 0.01), and serum C-reactive protein (r = 0.494; p < 0.01). Furthermore, IL-6 levels were significantly correlated with peripheral blood platelet counts (r = 0.447; p < 0.001). These results suggest that (1) IL-6 is produced locally in pleural space, (2) pleural IL-6 level is helpful for differential diagnosis, and (3) locally produced IL-6 could leak to circulation and cause systemic effects such as the induction of C-reactive protein and thrombocytosis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1395742     DOI: 10.1378/chest.102.4.1055

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

1.  Potential role of interleukin 6 in reactive thrombocytosis and acute phase response in pulmonary tuberculosis.

Authors:  E Unsal; S Aksaray; D Köksal; T Sipit
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

2.  Adjustments of serum lactate dehydrogenase isoenzymes and their significance in monitoring the treatment in patients with tubercular pyothorax.

Authors:  Riaz Ahmad; Mumtaz Alam; M Faisal Siddiqui; Absar-Ul Hasnain
Journal:  Indian J Clin Biochem       Date:  2008-06-11

3.  Pericardial cytokines in neoplastic, autoreactive, and viral pericarditis.

Authors:  Arsen D Ristić; Sabine Pankuweit; Ružica Maksimović; Rainer Moosdorf; Bernhard Maisch
Journal:  Heart Fail Rev       Date:  2013-05       Impact factor: 4.214

Review 4.  Malignant Pleural Effusions-A Window Into Local Anti-Tumor T Cell Immunity?

Authors:  Nicola Principe; Joel Kidman; Richard A Lake; Willem Joost Lesterhuis; Anna K Nowak; Alison M McDonnell; Jonathan Chee
Journal:  Front Oncol       Date:  2021-04-27       Impact factor: 6.244

5.  The differential diagnostic values of cytokine levels in pleural effusions.

Authors:  Saadet Akarsu; A Nese Citak Kurt; Yasar Dogan; Erdal Yilmaz; Ahmet Godekmerdan; A Denizmen Aygun
Journal:  Mediators Inflamm       Date:  2005-02-24       Impact factor: 4.711

6.  Combining ADA, protein and IFN-gamma best allows discrimination between tuberculous and malignant pleural effusion.

Authors:  Y C Kim; K O Park; H S Bom; S C Lim; H K Park; H J Na; J H Park
Journal:  Korean J Intern Med       Date:  1997-06       Impact factor: 2.884

7.  Analysis of Cytokine Levers in Pleural Effusions of Tuberculous Pleurisy and Tuberculous Empyema.

Authors:  Lei Yang; Yan-Jie Hu; Fu-Gen Li; Xiu-Jun Chang; Tian-Hui Zhang; Zi-Tong Wang
Journal:  Mediators Inflamm       Date:  2016-02-29       Impact factor: 4.711

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.